U.S. Life Sciences Stock News

Vertex Pharmaceuticals (NasdaqGS:VRTX) and CRISPR Therapeutics are ramping up patient treatments with Casgevy, a gene-editing therapy. Casgevy is approved for sickle cell disease and beta thalassemia, marking a key step in bringing gene-editing into routine clinical use. The current focus is on moving from approval to broader real-world deployment across eligible patient populations. For you as an investor, Casgevy sits at the intersection of Vertex's established role in serious diseases...

Recent analysis shows that over the past two years Greenbrier Companies has faced declining unit sales, softer demand, a 14% gross margin that trails peers, and free cash flow shortfalls, all of which have prompted fresh scrutiny of its operating model. A key concern is that weaker margins and cash generation may limit Greenbrier’s ability to fund marketing, innovation, and other investments needed to strengthen its competitive position. We’ll now examine how concerns about declining unit...

If you are wondering whether Liberty Latin America is priced attractively right now, you are not alone. The stock's recent moves have raised fresh questions about what a fair value really looks like. The share price sits at US$7.73, with returns of 6.5% year to date, 7.2% over 1 year, 3.2% over 30 days and a 6.0% decline over the last week, alongside longer term declines of 12.5% over 3 years and 31.2% over 5 years. These mixed returns come as investors continue to reassess Liberty Latin...

On February 17, 2026, Global Business Travel Group, Inc. reaffirmed its full-year 2026 revenue guidance of 19%–21% growth to US$3.24–US$3.30 billion and expanded its share repurchase authorization to US$600 million after completing US$100 million of buybacks covering 2.57% of its shares. The combination of higher buyback capacity and continued revenue growth guidance highlights management’s confidence in cash generation, post‑CWT integration progress, and the role of AI-enabled offerings in...

TG Therapeutics (TGTX) is back in focus after publishing five year data from the open label extension of its Phase 3 ULTIMATE I and II BRIUMVI trials in relapsing multiple sclerosis, highlighting durable efficacy and safety. See our latest analysis for TG Therapeutics. The latest BRIUMVI data arrive as TG Therapeutics trades at US$29.23, with a 7 day share price return of 1.42% but a 30 day share price return decline of 4.38%. A 3 year total shareholder return of 72.96% contrasts with a 5...

Integer Holdings Corporation has released its fourth-quarter and full-year 2025 results, reporting higher quarterly sales of US$472.06 million and net income of US$48.61 million, alongside full-year sales of US$1.85 billion but lower annual net income of US$102.81 million compared with the prior year. The company also issued 2026 guidance calling for US$1.83–1.88 billion in sales and diluted EPS of US$3.53–4.01, framing investor expectations amid earlier guidance concerns and ongoing...

Occidental Petroleum (NYSE:OXY) has launched a series of cash tender offers for certain senior notes and debentures. The company is using proceeds from the completed US$9.7b OxyChem divestiture to reduce debt. Alongside the liability actions, Occidental has announced an 8% quarterly dividend increase. Occidental Petroleum, a large upstream and integrated energy company, is in a new phase of balance sheet repair following its Anadarko acquisition period. The combination of debt tenders and a...

Axogen recently confirmed it met the Minervini Trend Template, signaling an institution-led uptrend supported by improving earnings, sales trends, and analyst estimate revisions. At the same time, management’s participation in multiple high-profile investor conferences has increased visibility around Axogen’s shift toward maintained profitability and growth-focused execution. We’ll now explore how Axogen’s institution-backed uptrend and upcoming investor conference participation may...

Luckin Coffee Inc. has opened its 30,000th store, its first “Origin Flagship” in Shenzhen, featuring an immersive premium coffee experience, global supply chain storytelling, and LEED Platinum, zero-carbon design. This flagship marks a shift from pure expansion to emphasizing higher-quality offerings, global sourcing integration, and sustainability, potentially reshaping how the brand competes in China’s maturing coffee market. Next, we’ll assess how this new Origin Flagship concept, with...

If you are wondering whether Evercore's current share price offers good value or is running ahead of itself, you are not alone. The stock closed at US$331.04, with returns of 24.6% over 1 year and very large gains over 5 years, while the last 7 days and 30 days reflect declines of 4.2% and 12.6%. The year-to-date return is a 5.8% decline. Recent news coverage has focused on Evercore's role as an independent investment banking adviser and its position within global deal making. This helps...

Raymond James Financial (NYSE:RJF) has hired a private client group team managing substantial client assets from a competitor. The advisors previously sat on the LPL Financial platform, which had recently acquired Commonwealth Financial Network. This move expands Raymond James's wealth management footprint and adds scale to its private client group business. For investors watching NYSE:RJF, the recruitment comes with the stock around $161.16, after a 53.8% return over 3 years and 111.5%...

Carrier Global (CARR) just raised its quarterly dividend to US$0.24 per share, even as residential HVAC sales remain under pressure. This move highlights management’s focus on shareholder returns alongside growing commercial and data center demand. See our latest analysis for Carrier Global. Carrier’s share price has cooled off in the very short term, with a 1 day share price return of 3.16% decline and 7 day share price return of 4.10% decline. However, the 30 day and 90 day share price...

If you are wondering whether IDEX is fairly priced at around US$208.98 per share, you are not alone; many investors are asking if the current tag lines up with the company’s fundamentals. The stock has had mixed returns recently, with a 1.2% decline over the past 7 days, a 6.1% gain over the last 30 days, a 16.7% return year to date and a 6.8% return over the past year, while the 3 year return is a 3.2% decline and the 5 year return sits at 12.4%. Recent attention on IDEX has been shaped by...

Liberty Energy (NYSE:LBRT) is expanding into distributed power generation aimed at gigawatt scale data center demand through its Liberty Power Innovations unit. The company is also advancing its position in electric fracking technology, focusing on lower emissions and high power efficiency at the wellsite. Together, these initiatives reflect a material shift beyond traditional oilfield services into energy support for digital infrastructure. Liberty Energy, known primarily for its hydraulic...

If you are wondering whether Daktronics at around US$27.48 is still good value after a strong run, or if you are late to the party, this article will focus squarely on what the current price implies. The stock has returned 5.0% over the last 7 days, 26.7% over the past month, 38.5% year to date and 65.4% over the last year, with a very large 3 year gain and a 396.0% return over 5 years. This naturally raises questions about how much optimism is already reflected in the price. These moves...

If you are wondering whether Getty Realty is still fairly priced after its recent run, or if the market is overlooking something in this REIT, this article explains what the current share price might imply about its value. The stock recently closed at US$31.41, with a 4.9% decline over the last 7 days, a 5.3% gain over 30 days, and returns of 14.0% year to date, 11.1% over 1 year, 8.8% over 3 years, and 49.9% over 5 years. Recent headlines around Getty Realty have focused on its role as a...

Amphenol (NYSE:APH) is being highlighted as a strong growth stock on the back of favorable analyst recommendations. Analysts are pointing to significant earnings per share growth expectations as a key support for this view. Positive revisions to earnings estimates have recently strengthened the investment case for the company. Amphenol, a major supplier of interconnect and sensor solutions, is involved in electronic content in areas such as communications, automotive, industrial and...

Sterling Infrastructure, Inc. reported that it had topped earnings estimates in each of the last four quarters and was expected to release its fourth-quarter 2025 results on February 25, 2026, with the Zacks Consensus Estimate calling for earnings per share of $2.66, implying very large year-over-year growth. Management also highlighted structurally higher operating margins and a growing Transportation Solutions backlog, suggesting its focus on disciplined bidding and complex, higher-margin...

Lam Research opened a new office in Boise, Idaho, to work more closely with Micron Technology on research and high volume manufacturing. The move is aimed at supporting memory manufacturing tied to AI focused semiconductor demand. For investors watching Lam Research, NasdaqGS:LRCX, this update comes with a current share price of $240.09. The stock shows very large 3 year gains and a strong 1 year move of 176.4%. Year to date it is up 29.7%, and 7.7% over the past 30 days. A 2.1% gain over...

Booking Holdings Inc. has released its fourth-quarter and full-year 2025 results, reporting revenue of US$6,349 million and net income of US$1,428 million for the quarter, and full-year revenue of US$26.92 billion with net income of US$5.40 billion, alongside higher quarterly earnings per share but lower full-year earnings per share versus 2024. The earnings beat on adjusted fourth-quarter profit and revenue, helped by increased room nights and bookings, highlights the impact of Booking’s...

National HealthCare (NHC) has just expanded its board from seven to nine directors, adding geriatric medicine leader Dr. David Gifford and long-term care operator and business executive Andrew Adams. The move is aimed at deepening clinical and operational oversight. See our latest analysis for National HealthCare. Those board additions come as National HealthCare’s share price sits at US$162.10 following a 1-day share price return of a 1.7% decline and a 7-day share price return of a 3.7%...

Carvana, NYSE:CVNA, is facing accounting fraud allegations tied to claims of earnings overstatement and undisclosed related party transactions. The company is under an active SEC investigation while questions build around substantial insider selling activity. These issues are emerging as Carvana reports record vehicle sales and strong revenue, but with pressured margins and elevated operating costs. For investors watching NYSE:CVNA, the backdrop is complicated. The stock trades at $361.53,...

If you are wondering whether HA Sustainable Infrastructure Capital's current share price lines up with its underlying worth, this article is designed to walk you through that question clearly and calmly. The stock most recently closed at US$37.77, with returns of 1.5% over 7 days, 9.6% over 30 days, 18.7% year to date, 38.1% over 1 year and a 45.5% return over 3 years, while the 5 year return stands at an 18.1% decline. Recent news coverage on HA Sustainable Infrastructure Capital has...

Recent optimism around Cigna Group (CI) is being shaped by two developments: a policy shift at Evernorth Behavioral Health to remove prior authorization for TMS therapy, and a series of upbeat analyst actions. See our latest analysis for Cigna Group. Against this backdrop, Cigna Group’s share price at US$290.12 comes after a 6.58% 1 month share price return and a 7.61% 3 month share price return. Its 5 year total shareholder return of 47.54% contrasts with a flat 1 year total shareholder...